Cargando…
V-ATPase-dependent repression of androgen receptor in prostate cancer cells
Prostate Cancer (PCa) is the most commonly diagnosed cancer and the third leading cause of death for men in the United States. Suppression of androgen receptor (AR) expression is a desirable mechanism to manage PCa. Our studies showed that AR expression was reduced in LAPC4 and LNCaP PCa cell lines...
Autores principales: | Licon-Munoz, Yamhilette, Fordyce, Colleen A., Hayek, Summer Raines, Parra, Karlett J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034745/ https://www.ncbi.nlm.nih.gov/pubmed/29988966 http://dx.doi.org/10.18632/oncotarget.25641 |
Ejemplares similares
-
F-actin reorganization by V-ATPase inhibition in prostate cancer
por: Licon-Munoz, Yamhilette, et al.
Publicado: (2017) -
Advances in targeting the vacuolar proton-translocating ATPase (V-ATPase) for anti-fungal therapy
por: Hayek, Summer R., et al.
Publicado: (2014) -
Reciprocal Regulation of V-ATPase and Glycolytic Pathway Elements in Health and Disease
por: Hayek, Summer R., et al.
Publicado: (2019) -
Regulation of expression of Na(+),K(+)-ATPase in androgen-dependent and androgen-independent prostate cancer
por: Blok, L J, et al.
Publicado: (1999) -
A high-throughput imaging and quantification pipeline for the EVOS imaging platform
por: Klimaj, Stefan Donovan, et al.
Publicado: (2020)